HIP fracture accelerated surgical treatment and care track-2 (HIP attack-2) trial

Active Cooperative Agreement Awarded Last action

Award ID
U01AR080377
Recipient
Awarding agency
Obligated
$4,315,836

Award facts

Completion date 85% complete
Originally
Place of performance
Baltimore, MD 21201, USA

Award details come from USAspending.gov.

Description

Abstract
The proposed trial, HIP attack-2, seeks to improve the outcomes of thousands of patients who present to the hospital with a HIP fracture and concomitant acute heart injury. Acute heart injury is characterized by an elevated serum troponin; this heart injury is often asymptomatic but can be identified in up to 20% of HIP fracture patients prior to surgery. These patients have a much worse prognosis than patients with no heart injury (i.e., 24% versus 8% 90-day mortality, respectively). Despite the magnitude of this problem, standard medical management has made little progress in improving the outcomes of these patients. The objective of the HIP attack-2 trial is to confirm the previous post-hoc subgroup findings by comparing accelerated surgery (

Transactions

Action Obligated Date
Amendment $530,134
Amendment $0
Amendment $795,573
Amendment $0
Amendment $982,071
Amendment $1,004,029
Original award $1,004,029

Subawards

Subrecipient Amount Awarded
Dartmouth-Hitchcock Clinic HIP fracture Accelerated surgical TreaTment And Care tracK-2 (HIP ATTACK-2) trial. $19,530
Yale Univ $35,175
University Of California, Davis $37,191
Mayo Clinic $65,000
Saint Luke's Hospital Of Bethlehem, Pennsylvania $77,000
University Of California Irvine HIP fracture Accelerated surgical TreaTment And Care tracK-2 (HIP ATTACK-2) trial $97,429
Hamilton Health Sciences Corporation $610,286
Hamilton Health Sciences Corporation HIP fracture Accelerated surgical TreaTment And Care tracK-2 (HIP ATTACK-2) trial. $550,353
Mcmaster University McMaster University will serve as the Methods Center for this clinical study and will enter into a contractual agreement with all participating clinical sites. $477,388

Quick answers

Who received award U01AR080377?

U01AR080377 was awarded to University Of Maryland, Baltimore by National Insititue of Arthritis and Musculoskeletal and Skin Diseases (National Institutes of Health) on August 1, 2022.

How much is award U01AR080377 worth?

$4,315,836 has been obligated on U01AR080377.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award